EGCG inhibits activation of the insulin-like growth factor-1 receptor in human colon cancer cells
- 12 July 2005
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 334 (3) , 947-953
- https://doi.org/10.1016/j.bbrc.2005.06.182
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Modulation of signal transduction by tea catechins and related phytochemicalsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2005
- Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysisPublished by Elsevier ,2004
- Lipid raft‐associated catechin suppresses the FcϵRI expression by inhibiting phosphorylation of the extracellular signal‐regulated kinase1/2FEBS Letters, 2003
- Treatment of epigallocatechin‐3‐gallate inhibits matrix metalloproteinases‐2 and ‐9 via inhibition of activation of mitogen‐activated protein kinases, c‐jun and NF‐κB in human prostate carcinoma DU‐145 cellsThe Prostate, 2003
- Association of Suppression of Extracellular Signal-Regulated Kinase Phosphorylation by Epigallocatechin Gallate with the Reduction of Matrix Metalloproteinase Activities in Human Fibrosarcoma HT1080 CellsJournal of Agricultural and Food Chemistry, 2003
- Protein Kinase C-dependent, CCAAT/Enhancer-binding Protein β-mediated Expression of Insulin-like Growth Factor I GenePublished by Elsevier ,2002
- Inhibition of Carcinogenesis by TeaAnnual Review of Pharmacology and Toxicology, 2002
- The growth hormone–insulin-like growth factor-I axis and colorectal cancerTrends in Molecular Medicine, 2001
- IGF-II/IGF-I receptor pathway up-regulates COX-2 mRNA expression and PGE2 synthesis in Caco-2 human colon carcinoma cellsOncogene, 2000
- Green tea compounds inhibit tyrosine phosphorylation of PDGF β‐receptor and transformation of A172 human glioblastomaFEBS Letters, 2000